Orient Pharma , Ltd. Intangible Assets

The latest intangible assets for 4166.TWO is $380M as of June 2026. That compares with $440M in the prior-year period — down 12.8% year over year. Investors often review this figure alongside Orient Pharma , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4166.TWO's intangible assets moved from $440M to $380M — a 12.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orient Pharma , Ltd.'s operating scale or balance-sheet position.

A intangible assets figure of $380M for 4166.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4166.TWO's intangible assets ($380M), review year-over-year change from $440M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.